Insider Trading & Ownership - Gengos Andrew

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gengos Andrew
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-05
Sale
2024-09-05
7:51 pm
Athira Pharma Inc.ATHAGengos Andrew
CFO and Chief Business Officer
1,272$0.566$72097,532
(Direct)
View
2024-01-05
Sale(A)
2024-02-16
4:34 pm
Athira Pharma Inc.ATHAGengos Andrew
CFO AND CHIEF BUSINESS OFFICER
1,208$2.91$3,51583,804
(Direct)
View
2023-01-05
Sale
2024-01-08
4:42 pm
Athira Pharma Inc.ATHAGengos Andrew
See Below
1,208$2.91$3,51583,804
(Direct)
View
2023-06-07
Purchase
2023-06-09
5:06 pm
Athira Pharma Inc.ATHAGengos Andrew
See Below
15,000$3.4297$51,44580,012
(Direct)
View
2023-06-02
Purchase
2023-06-06
7:36 pm
Athira Pharma Inc.ATHAGengos Andrew
See Below
65,012$2.9467$191,57265,012
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-20
Option Award
2024-09-05
7:51 pm
N/A
N/A
Athira Pharma Inc.ATHAGengos Andrew
CFO and Chief Business Officer
10,000$1.3497,532
(Direct)
View
2024-09-03
Option Award
2024-09-05
7:51 pm
N/A
N/A
Athira Pharma Inc.ATHAGengos Andrew
CFO and Chief Business Officer
5,000$097,532
(Direct)
View
2024-02-14
Option Award
2024-02-16
4:48 pm
N/A
2034-02-13
Athira Pharma Inc.ATHAGengos Andrew
CFO AND CHIEF BUSINESS OFFICER
280,000$0280,000
(Direct)
View
2024-01-04
Option Award(A)
2024-02-16
4:34 pm
N/A
N/A
Athira Pharma Inc.ATHAGengos Andrew
CFO AND CHIEF BUSINESS OFFICER
5,000$083,804
(Direct)
View
2023-01-04
Option Award
2024-01-08
4:42 pm
N/A
N/A
Athira Pharma Inc.ATHAGengos Andrew
See Below
5,000$083,804
(Direct)
View
2023-05-18
Option Award
2023-05-22
5:53 pm
N/A
2033-05-17
Athira Pharma Inc.ATHAGengos Andrew
See Below
400,000$0400,000
(Direct)
View

Ownership
2023-05-22
5:51 pm
N/A
N/A
Athira Pharma Inc.ATHAGengos Andrew
See Below
0$00
(Direct)
View
2022-02-22
Option Award
2022-02-24
4:57 pm
N/A
2032-02-22
Cyteir Therapeutics Inc.CYTGengos Andrew
Chief Business Officer
35,000$035,000
(Direct)
View

Ownership
2021-06-17
9:15 pm
N/A
N/A
Cyteir Therapeutics Inc.CYTGengos Andrew
Chief Business Officer
0$0378,682
(Direct)
View
(A) Indicate amendment filing.